SwiftScale Biologics

Swiftscale Biologics Utilizes Cell-Free Protein Synthesis to Advance Next-Generation Protein Therapies. Our Cell-Free Protein Synthesis (CFPS) technology eliminates the limitations of using live cells in drug manufacturing, reducing production time, minimizing batch-to-batch variability, and enhancing the scalability of difficult-to-produce proteins. With the biopharmaceutical industry’s growing demand for multispecific drugs and other complex biologics, CFPS represents a promising avenue for producing these next-generation therapies.